Ronit Haklai

694 citations
21 papers · 605 · h-index 13

Impact in

    • Protein Kinase Regulation and GTPase Signaling
    • PI3K/AKT/mTOR signaling in cancer
    • Cell death mechanisms and regulation
    • Melanoma and MAPK Pathways
    • Cancer-related gene regulation
    • Ubiquitin and proteasome pathways

Papers in

    • Protein Kinase Regulation and GTPase Signaling 6
    • Ubiquitin and proteasome pathways 4
    • PI3K/AKT/mTOR signaling in cancer 3
    • Cell death mechanisms and regulation 2
    • Cancer-related gene regulation 2
    • Plant biochemistry and biosynthesis 2
    • Peptidase Inhibition and Analysis 2

Ronit Haklai

21 papers receiving 600 citations

Peers

Ronit Haklai
Comparison fields: 5 of 70
  • Molecular Biology 386
  • Cancer Research 65
  • Developmental Neuroscience 18
  • Oncology 111
  • Neurology 35
Replace Xifeng Fei with:
Xifeng Fei China
Gabriele Riva Italy
Julie Dwyer France
Niyati Jhaveri United States
Xiang Lu China
Jun-Kyum Kim South Korea
Evelyn Aranda United States
Nazanin Majd United States
Cassandra L. Buchheit United States
Se-Yeong Oh South Korea
Ronit Haklai relative to Xifeng Fei China Xifeng Fei's profile →
Citations per field
00.5×1.6×
Xifeng Fei · 1×
Citations per year

Countries citing papers authored by Ronit Haklai

Since Specialization
Citations

This map shows the geographic impact of Ronit Haklai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronit Haklai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronit Haklai more than expected).

Fields of papers citing papers by Ronit Haklai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronit Haklai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronit Haklai. The network helps show where Ronit Haklai may publish in the future.

Co-authors

The 25 scholars most cited alongside Ronit Haklai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ronit Haklai Line = papers co-authored together Ronit Haklai links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1995176
2 200874
3
The Ras inhibitor S-trans,trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance.
200266
4 200554
5 200751
6 201042
7 201531
8 198015
9 199213
10 199012
11 200912
12 199312
13 199312
14 200611
15 19936
16 20096
17 20135
18 20063
19 19972
20 19971

About Ronit Haklai

Ronit Haklai is a scholar working on Molecular Biology, Oncology, Cell Biology, Biochemistry and Cancer Research, having authored 21 papers that have together received 605 indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (6 papers), Ubiquitin and proteasome pathways (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cell death mechanisms and regulation (2 papers), Cellular transport and secretion (2 papers), Cancer-related gene regulation (2 papers), Plant biochemistry and biosynthesis (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Molecular Biology (386 citations), Cancer Research (65 citations), Developmental Neuroscience (18 citations), Oncology (111 citations) and Neurology (35 citations). Ronit Haklai has collaborated with scholars based in Israel and United States. Frequent co-authors include Yoel Kloog, Gilad Ben‐Baruch, Daniele Marciano, Yaacov Egozi, Michal Marom, Galit Elad‐Sfadia, Adi Zundelevich, Shlomo Rotshenker, Fanny Reichert and Burkhard Jansen. Their work appears in journals such as International Journal of Gynecological Cancer, FEBS Letters, Molecular Cancer Therapeutics, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact